NDA 203395 describes BROMFENAC SODIUM, which is a drug marketed by
Alembic,
Amring Pharms,
Apotex,
Chartwell Rx,
Coastal Pharms,
Eugia Pharma,
Gland Pharma Ltd,
Lupin Ltd,
Rising, and
Sentiss, and is included in thirteen NDAs. It is available from
seven suppliers. Additional details are available on the
BROMFENAC SODIUM profile page.
The generic ingredient in BROMFENAC SODIUM is
bromfenac sodium. Ten
suppliers are listed for this compound. Additional details are available on the
bromfenac sodium profile page.